{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T19:40:43Z","timestamp":1759347643603,"version":"build-2065373602"},"reference-count":11,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T00:00:00Z","timestamp":1612483200000},"content-version":"vor","delay-in-days":1223,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Journal of Medical Microbiology"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.4103\/ijmm.ijmm_17_386","type":"journal-article","created":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T05:47:02Z","timestamp":1517377622000},"page":"585-587","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Dosing Strategy Based on Prevailing Aminoglycoside Minimum Inhibitory Concentration in India: Evidence and Issues"],"prefix":"10.1016","volume":"35","author":[{"given":"Balaji","family":"Veeraraghavan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agila Kumari","family":"Pragasam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abi","family":"Manesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priscilla","family":"Rupali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramya","family":"Iyadurai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilla","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sangeeta","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Indranil","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhaskar Narayan","family":"Chaudhuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.S.","family":"Chitnis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhole","family":"Tapan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4103\/ijmm.IJMM_17_386_bib1","first-page":"CD003344","article-title":"Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis","author":"Paul","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.4103\/ijmm.IJMM_17_386_bib2","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1097\/CCM.0b013e3181e96b91","article-title":"A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: A meta-analytic\/meta-regression study","volume":"38","author":"Kumar","year":"2010","journal-title":"Crit Care Med"},{"key":"10.4103\/ijmm.IJMM_17_386_bib3","doi-asserted-by":"crossref","first-page":"e1001974","DOI":"10.1371\/journal.pmed.1001974","article-title":"Antibiotic resistance in India: Drivers and opportunities for action","volume":"13","author":"Laxminarayan","year":"2016","journal-title":"PLoS Med"},{"key":"10.4103\/ijmm.IJMM_17_386_bib4","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.drup.2010.08.003","article-title":"Aminoglycoside modifying enzymes","volume":"13","author":"Ramirez","year":"2010","journal-title":"Drug Resist Updat"},{"key":"10.4103\/ijmm.IJMM_17_386_bib5","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.idc.2016.02.011","article-title":"Aminoglycoside resistance: The emergence of acquired 16S ribosomal RNA methyltransferases","volume":"30","author":"Doi","year":"2016","journal-title":"Infect Dis Clin North Am"},{"key":"10.4103\/ijmm.IJMM_17_386_bib6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2014.07.006","article-title":"The effect of pathophysiology on pharmacokinetics in the critically ill patient \u2013 Concepts appraised by the example of antimicrobial agents","volume":"77","author":"Blot","year":"2014","journal-title":"Adv Drug Deliv Rev"},{"key":"10.4103\/ijmm.IJMM_17_386_bib7","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1128\/AAC.37.5.1025","article-title":"Nonparametric approach to population pharmacokinetics in oncology patients receiving aminoglycoside therapy","volume":"37","author":"Inciardi","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4103\/ijmm.IJMM_17_386_bib8","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1086\/520991","article-title":"Back to the future: Using aminoglycosides again and how to dose them optimally","volume":"45","author":"Drusano","year":"2007","journal-title":"Clin Infect Dis"},{"year":"2011","series-title":"Manual of Clinical Microbiology","key":"10.4103\/ijmm.IJMM_17_386_bib9"},{"year":"2017","series-title":"Performance Standards for Antimicrobial Susceptibility Testing; Twenty seventh Informational Supplement. CLSI document M100-27","key":"10.4103\/ijmm.IJMM_17_386_bib10"},{"key":"10.4103\/ijmm.IJMM_17_386_bib11","unstructured":"European Committee on Antimicrobial susceptibility Testing Breakpoint Tables for Interpretation of MICs and Zone Diameters EUCAST; 2015."}],"container-title":["Indian Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085720303984?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085720303984?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T19:17:06Z","timestamp":1759346226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0255085720303984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0255085720303984"],"URL":"https:\/\/doi.org\/10.4103\/ijmm.ijmm_17_386","relation":{},"ISSN":["0255-0857"],"issn-type":[{"type":"print","value":"0255-0857"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dosing Strategy Based on Prevailing Aminoglycoside Minimum Inhibitory Concentration in India: Evidence and Issues","name":"articletitle","label":"Article Title"},{"value":"Indian Journal of Medical Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4103\/ijmm.IJMM_17_386","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2017 Indian Journal of Medical Microbiology. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}